|
C15ORF42 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.727700E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.619900E-02 |
| Normal-vs-Stage2 |
5.248300E-02 |
| Normal-vs-Stage3 |
5.344100E-02 |
| Normal-vs-Stage4 |
6.021400E-01 |
| Stage1-vs-Stage2 |
4.855400E-01 |
| Stage1-vs-Stage3 |
7.047000E-01 |
| Stage1-vs-Stage4 |
2.253400E-01 |
| Stage2-vs-Stage3 |
6.638200E-01 |
| Stage2-vs-Stage4 |
1.782360E-01 |
| Stage3-vs-Stage4 |
2.135000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.372180E-01 |
| Normal-vs-AfricanAmerican |
8.207600E-01 |
| Normal-vs-Asian |
2.675500E-02 |
| Caucasian-vs-AfricanAmerican |
1.946760E-01 |
| Caucasian-vs-Asian |
1.730350E-01 |
| AfricanAmerican-vs-Asian |
6.619800E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.859180E-01 |
| Normal-vs-Female |
3.026100E-02 |
| Male-vs-Female |
4.908000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.072500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.297500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.153400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.047200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.619200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.753400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.505000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.896800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.917000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.055200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.951800E-01 |
| Classical-VS-Follicular |
4.020400E-02 |
| Classical-VS-Other |
2.814300E-02 |
| Classical-VS-Normal |
1.825840E-01 |
| Tall-VS-Follicular |
6.507800E-01 |
| Tall-VS-Other |
3.183400E-01 |
| Tall-VS-Normal |
8.144000E-02 |
| Follicular-VS-Other |
4.982400E-01 |
| Follicular-VS-Normal |
8.276600E-03 |
| Other-VS-Normal |
5.080600E-03 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.886190E-02 |
| Normal-vs-N1 |
9.447700E-02 |
| N0-vs-N1 |
7.328200E-01 |
|
|
